期刊
CANCER CELL
卷 16, 期 6, 页码 498-509出版社
CELL PRESS
DOI: 10.1016/j.ccr.2009.10.014
关键词
-
资金
- Ohio State University Targeted Investment
- Associazione Italiana Ricerca sul Cancro
- NATIONAL CANCER INSTITUTE [R01CA135030] Funding Source: NIH RePORTER
Lung and liver cancers are among the most deadly types of cancer. Despite improvements in treatment over the past few decades, patient survival remains poor, underlining the need for development of targeted therapies. MicroRNAs represent a class of small RNAs frequently deregulated in human malignancies. We now report that miR-221&222 are overexpressed in aggressive non-small cell lung cancer and hepatocarcinoma cells, as compared with less invasive and/or normal lung and liver cells. We show that miR-221&222, by targeting PTEN and TIMP3 tumor suppressors, induce TRAIL resistance and enhance cellular migration through the activation of the AKT pathway and metallopeptidases. Finally, we demonstrate that the MET oncogene is involved in miR-221&222 activation through the c-Jun transcription factor.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据